Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
---|
02/19/2004 | WO2004014887A1 Process for producing trifluoromethyl-substituted 2-alkoxyacetophenone derivatives |
02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
02/19/2004 | WO2004014827A1 Hydroxylation process for aromatic compounds containing a dioxa- heterocyclic system |
02/19/2004 | WO2004000793A3 Aminoacetonitrile derivatives suitable for controlling parasites |
02/19/2004 | US20040034231 Amidinophenyl-4-aminoacetic acid derivative is useful for treating diseases such as thrombosis, apoplexy, cardiac infarction, inflammation and arteriosclerosis, which are associated with coagulation factors xa, IXa and thrombin |
02/19/2004 | US20040034072 Aza-amino acid derivatives (factor Xa inhibitors 15) |
02/19/2004 | US20040034048 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
02/19/2004 | US20040034035 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
02/19/2004 | US20040034027 E.g.N-(carbamimidoylphenyl)-N'-((1-(4-nitrophenyl)ethyl-2-phenyl -malonamide formate; reversible enzyme inhibitors of blood factor VIIa; a strong antithrombotic to treat thrombo-embolic diseases and restenoses; cardiovascular disorders |
02/19/2004 | DE10235624A1 New fused tetracyclic compounds, e.g. endiandric acid H obtained from the plant Beilschmieda fulva, are c-maf and NFAT inhibitors useful for treating allergy or asthma |
02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
02/18/2004 | EP1389189A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
02/18/2004 | EP1286953B1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
02/18/2004 | EP1178958B1 N-cyanomethyl amides as protease inhibitors |
02/18/2004 | EP0839134B1 Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
02/18/2004 | CN1138769C Process for synthesis of 5-(alpha-hydroxyalkyl) benzo[1,3] dioxols |
02/18/2004 | CN1138752C Novel carboxylic ester derivatives, process for producing same, and insecticide or insectifuge contg. same |
02/17/2004 | US6693190 Tetraazacyclododecane macrocycle derivatives including metal complexes; magnetic resonance imaging agents |
02/17/2004 | US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia |
02/17/2004 | US6692874 Electrolytes and lithium ion battery using the same |
02/17/2004 | CA2124680C Piperazine derivatives as 5-ht1a antagonists |
02/12/2004 | WO2004013121A2 Preparation of lactic acid derivatives and their use |
02/12/2004 | WO2004013120A1 Novel benzodioxoles |
02/12/2004 | WO2004013119A1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
02/12/2004 | WO2003095437A8 Aralkyl formyl-alkyl piperazine derivatives and their uses as cerebral nerve protective agent |
02/12/2004 | WO2003017948A3 Aryl tetrahydronaphthalene derivatives |
02/12/2004 | US20040030141 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them |
02/12/2004 | US20040030130 Methods of asymmetrically synthesizing enantiomers of casodex, its derivatives and intermediates thereof |
02/12/2004 | US20040030129 NF-kappaB inhibitor comprising phenylmethyl benzoquinone as an active ingredient |
02/12/2004 | US20040029976 1- Deoxy baccatin III, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof |
02/12/2004 | US20040029880 Anthranyl amides and their use as medicaments |
02/12/2004 | DE10232780A1 Co-Tenside auf Basis von Aldehyden Co-surfactants based on aldehydes |
02/12/2004 | CA2494146A1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
02/11/2004 | EP1047411B1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation |
02/11/2004 | EP0859608B1 Treating niddm with rxr agonists |
02/11/2004 | CN1474803A Novel amide derivatives and medicinal use thereof |
02/10/2004 | US6689174 N-benzyl-p-phenylenediamine-derivatives containing coloring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives |
02/05/2004 | WO2004011418A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
02/05/2004 | WO2004011410A1 Chemical compounds |
02/05/2004 | WO2003075857A3 Amino-methyl substituted tetracycline compounds |
02/05/2004 | US20040024227 For continuous processing |
02/05/2004 | US20040024060 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
02/05/2004 | US20040024059 Novel pleuromutilin derivatives |
02/05/2004 | US20040023954 Hypotensive drugs Bimatoprost, Latanaprost, Unoprostone, Travoprost and prostaglandin H2 1-ethanolamide or of structurally closely related analogs, are pro-drugs which hydrolyze under physiological conditions to provide |
02/05/2004 | CA2494668A1 Chemical compounds |
02/04/2004 | EP1386921A1 Intermediates |
02/04/2004 | EP1385825A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
02/04/2004 | EP1385493A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties |
02/04/2004 | EP1385485A1 Bioerodible poly(orthoesters) from dioxolane-based diketene acetals |
02/03/2004 | US6686483 Reacting an oxidizer with an olefin in presence of ketone |
02/03/2004 | US6686482 1,2- methylenedioxy-benzene and glyoxylic acid are reacted to form 3, 4-methylenedioxymandelic acid in presence of a strong acid, solvent extraction, neuturalization with a base, separtion of organic and aqueous phase, oxidation with hno3 |
02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
02/03/2004 | US6686350 Cell adhesion inhibitors |
01/29/2004 | WO2004009564A2 Co-surfactants based on aldehydes |
01/29/2004 | WO2004009552A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
01/29/2004 | WO2004009533A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
01/29/2004 | WO2004009017A2 Modulators of the glucocorticoid receptor and method |
01/29/2004 | WO2003066035A3 Compounds for inhibiting insulin secretion and methods related thereto |
01/29/2004 | WO2003040080A3 Lipoxin a4 analogs |
01/29/2004 | US20040019106 Cyano and carboxy derivatives of substituted styrenes; inhibitors of tumor necrosis factor alpha, nuclear factor kappa B, and phosphodiesterase |
01/29/2004 | US20040019086 Aminediols for the treatment of Alzheimer's disease |
01/29/2004 | US20040019072 Dimer-selective RXR modulators and methods for their use |
01/29/2004 | US20040019056 Anititumoral analogs of et-743 |
01/29/2004 | US20040019041 Method for the production of imidazo-(1,2-C)(2,3)-benzodiazepines and intermediates in the production thereof |
01/29/2004 | US20040019039 Substituted piperazines and diazepanes |
01/29/2004 | US20040019021 Linked cyclitols and their polysulfated derivatives |
01/29/2004 | US20040016063 1,3-Dihydroxybenzene derivatives and colorants containing said compounds |
01/29/2004 | CA2493457A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
01/29/2004 | CA2492912A1 Co-surfactants based on aldehydes |
01/29/2004 | CA2492907A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
01/28/2004 | EP1383757A1 Antagonists of mcp-1 function and methods of use thereof |
01/28/2004 | EP1383733A2 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
01/28/2004 | EP1383731A1 Biaryl compounds as serine protease inhibitors |
01/28/2004 | CN1471509A 9-substituted minocycline compounds |
01/28/2004 | CN1136192C Aryl and hetaryl-sulfonamide derivatives, their preparation and use as endo thelin antagonists |
01/28/2004 | CN1135982C Process for preparing pharmaceutical composition containing N-acyl-2,3-benzodiazepine deriratives |
01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
01/27/2004 | US6683213 Chemical intermediates for pyridinedicarboxamide herbicides |
01/27/2004 | US6683211 Fungicides for crops |
01/27/2004 | US6683205 Synthesis of 2-aryl propenoic acid esters for the production of non-steroidal anti-inflammatory drugs |
01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
01/27/2004 | US6683074 Cyclic amine derivatives-CCR-3 receptor antagonists |
01/27/2004 | US6683068 For therapy of tetracycline compound-responsive states, such as bacterial infections and neoplasms |
01/27/2004 | CA2213007C Stereoselective ring opening reactions |
01/27/2004 | CA2098147C Catalytic procedure for the preparation of organic carbonates |
01/22/2004 | WO2004007506A1 Ruthenium compounds, diamine ligands, and process for preparation of optically active alcohols |
01/22/2004 | WO2004006850A2 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
01/22/2004 | WO2003049690A3 Hiv integrase inhibitors |
01/22/2004 | WO2003044065A3 Microstructure modifier for anionic polymerization |
01/22/2004 | US20040014998 Process for the preparation of baccatin III derivatives |
01/22/2004 | US20040014796 Antiinflammatory agents; rheumatic diseases; antitumor agents |
01/22/2004 | US20040014784 Substituted propargylamines |
01/22/2004 | CA2492273A1 3, 10, and 12a substituted tetracycline compounds |
01/21/2004 | EP1382626A1 Modified isocyanates |
01/21/2004 | EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
01/21/2004 | EP1100774B1 Improved arylamine synthesis |
01/21/2004 | EP0811002B1 Benzylpiperidines and piperazines as muscarinic antagonists |
01/21/2004 | CN1469860A Aza-amino acid derivatives (factor XA-inhibitors 15) |
01/20/2004 | US6680401 Hydroboronation process |
01/20/2004 | US6680003 Chiral doping agents with variable spiral pitch induction and application thereof to a reflective color display |